ResMed Reports Q3 2026 Earnings with Revenue Growth and Margin Expansion
ResMed (RMD) reported Q3 2026 earnings with revenue of $1.43 billion, up 11% year-over-year, driven by growth in devices and masks. The company also saw an expansion in gross margin to 62.8%, up 290 basis points year-over-year, due to cost improvements and operational efficiencies.
Tickers: $RMD
Topics: device sales earnings report financial performance gross margin mask sales operational efficiency revenue growth